Real-time enrollment status for this pasc post acute sequelae of covid 19 clinical trial
Current Status
Recruiting
Checked: October 15, 2026 at 12:47 PM UTC
| NCT Number | NCT07278388 |
| Recruiting Status | Recruiting |
| Condition | PASC Post Acute Sequelae of COVID 19 |
| Phase | NA |
| Target Enrollment | 200 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Hugo W. Moser Research Institute at Kennedy Krieger, Inc. |
| Last Updated on CT.gov | December 12, 2025 (Dec 12, 2025) |
As of October 15, 2026: Clinical trial NCT07278388 is currently recruiting participants. This na study for pasc post acute sequelae of covid 19 is actively seeking new participants at 1 location across the United States. The study is sponsored by Hugo W. Moser Research Institute at Kennedy Krieger, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07278388 is actively recruiting participants as of October 15, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07278388 was last updated Dec 12, 2025 (December 12, 2025). HelloStudys verifies this status automatically.